{"id":344582,"date":"2026-11-12T10:41:57","date_gmt":"2026-11-12T05:11:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=344582"},"modified":"2026-11-12T10:41:57","modified_gmt":"2026-11-12T05:11:57","slug":"engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/","title":{"rendered":"3 Engines and Gensets Maker, Fermentation Based Pharma Maker and Airline Software Company Stocks With a Strong Future Roadmap: Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India: ROE of 12.9% to 38.1% and FY22 to FY26 revenue CAGR of 10.1% to 17.7%. Prices as of 11 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three engine, biotech and airline software stocks to watch are Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India. Their return on equity ranges from 12.9% to 38.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.1% to 17.7%. Accelya Solutions India has the highest return on equity at 38.1%, while Kirloskar Oil Engines has the fastest revenue growth at 17.7% a year. Prices are based on the 11 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Engine, biotech and airline software stocks bring together companies with a visible plan for the years ahead. Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India cover an engines and gensets maker, a fermentation based pharma maker and an airline software company.<\/p>\n<p>This list covers three engine, biotech and airline software stocks with complete current figures: Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#What_Are_Engine_Biotech_and_Airline_Software_Stocks\" title=\"What Are Engine, Biotech and Airline Software Stocks?\">What Are Engine, Biotech and Airline Software Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Engine_Biotech_and_Airline_Software_Stocks_at_a_Glance\" title=\"Engine, Biotech and Airline Software Stocks at a Glance\">Engine, Biotech and Airline Software Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Why_Do_Engine_Biotech_and_Airline_Software_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Engine, Biotech and Airline Software Stocks Have a Strong Roadmap in India?\">Why Do Engine, Biotech and Airline Software Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Why_Kirloskar_Oil_Engines_Features_Among_These_Engine_Biotech_and_Airline_Software_Stocks\" title=\"Why Kirloskar Oil Engines Features Among These Engine, Biotech and Airline Software Stocks\">Why Kirloskar Oil Engines Features Among These Engine, Biotech and Airline Software Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Why_Concord_Biotech_Features_Among_These_Engine_Biotech_and_Airline_Software_Stocks\" title=\"Why Concord Biotech Features Among These Engine, Biotech and Airline Software Stocks\">Why Concord Biotech Features Among These Engine, Biotech and Airline Software Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Why_Accelya_Solutions_India_Features_Among_These_Engine_Biotech_and_Airline_Software_Stocks\" title=\"Why Accelya Solutions India Features Among These Engine, Biotech and Airline Software Stocks\">Why Accelya Solutions India Features Among These Engine, Biotech and Airline Software Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Kirloskar_Oil_Engines_vs_Concord_Biotech_vs_Accelya_Solutions_India_on_Key_Financials\" title=\"Kirloskar Oil Engines vs Concord Biotech vs Accelya Solutions India on Key Financials\">Kirloskar Oil Engines vs Concord Biotech vs Accelya Solutions India on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Key_Risks_to_Check_Before_Investing_in_Engine_Biotech_and_Airline_Software_Stocks\" title=\"Key Risks to Check Before Investing in Engine, Biotech and Airline Software Stocks\">Key Risks to Check Before Investing in Engine, Biotech and Airline Software Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Final_Thoughts_on_Engine_Biotech_and_Airline_Software_Stocks\" title=\"Final Thoughts on Engine, Biotech and Airline Software Stocks\">Final Thoughts on Engine, Biotech and Airline Software Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#What_are_engine_biotech_and_airline_software_stocks\" title=\"What are engine, biotech and airline software stocks?\">What are engine, biotech and airline software stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Which_engine_biotech_and_airline_software_stocks_are_covered_in_this_list\" title=\"Which engine, biotech and airline software stocks are covered in this list?\">Which engine, biotech and airline software stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Why_do_engine_biotech_and_airline_software_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do engine, biotech and airline software stocks have a strong future roadmap in India?\">Why do engine, biotech and airline software stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#How_has_Kirloskar_Oil_Engines_performed_financially\" title=\"How has Kirloskar Oil Engines performed financially?\">How has Kirloskar Oil Engines performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#How_has_Concord_Biotech_performed_financially\" title=\"How has Concord Biotech performed financially?\">How has Concord Biotech performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#How_has_Accelya_Solutions_India_performed_financially\" title=\"How has Accelya Solutions India performed financially?\">How has Accelya Solutions India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#What_risks_should_investors_check_before_buying_engine_biotech_and_airline_software_stocks\" title=\"What risks should investors check before buying engine, biotech and airline software stocks?\">What risks should investors check before buying engine, biotech and airline software stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software-company-stocks-roadmap-highland-list\/#Is_this_list_of_engine_biotech_and_airline_software_stocks_investment_advice\" title=\"Is this list of engine, biotech and airline software stocks investment advice?\">Is this list of engine, biotech and airline software stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Engine_Biotech_and_Airline_Software_Stocks\"><\/span><strong>What Are Engine, Biotech and Airline Software Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Engine, biotech and airline software stocks are listed companies that build diesel engines and generator sets for farms, industry and backup power, make fermentation based active pharmaceutical ingredients and finished medicines, and provide revenue, fares and operations software to airlines. Their earnings depend on equipment demand, pharma sourcing and airline technology spending.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Engine_Biotech_and_Airline_Software_Stocks_at_a_Glance\"><\/span><strong>Engine, Biotech and Airline Software Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/kirloseng\/kirloskar-oil-engines-ltd-share-price-today\">Kirloskar Oil Engines<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,632.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28,722<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">53.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">44.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.48<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/concordbio\/concord-biotech-ltd-share-price-today\">Concord Biotech<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">597.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13,421<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">49.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/accelya\/accelya-solutions-india-ltd-share-price-today\">Accelya Solutions India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">972.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,422<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">38.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.06<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Accelya Solutions India trades at a P\/E below the industry P\/E, while Kirloskar Oil Engines and Concord Biotech trade above it, which reflects the growth the market already expects. Readers comparing engine, biotech and airline software stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Engine_Biotech_and_Airline_Software_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Engine, Biotech and Airline Software Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Engine, biotech and airline software stocks have a strong roadmap in India because steady need for backup power and farm equipment, growing demand for specialty pharma ingredients and rising air travel keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Engines and gensets.<\/strong> Farms and factories need reliable power.<\/li>\n<li><strong>Fermentation pharma.<\/strong> Drug makers need dependable biotech inputs.<\/li>\n<li><strong>Airline software.<\/strong> Airlines modernise fares and operations systems.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Kirloskar_Oil_Engines_Features_Among_These_Engine_Biotech_and_Airline_Software_Stocks\"><\/span><strong>Why Kirloskar Oil Engines Features Among These Engine, Biotech and Airline Software Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the engine, biotech and airline software stocks on this list, Kirloskar Oil Engines, based in Pune, makes diesel and gas engines, generator sets, pumps and power solutions for industrial, farm and infrastructure use.<\/p>\n<p>The company has a return on equity of 15.9%, a debt to equity ratio of 1.48 and a market capitalisation of Rs 28,722 crore. The stock trades at a P\/E of 53.7, above the industry P\/E of 44.4.<\/p>\n<p>Revenue rose from Rs 4,049 crore in FY22 to Rs 7,772 crore in FY26, a compound annual growth rate of 17.7%. Net profit grew from Rs 171 crore in FY22 to Rs 558 crore in FY26, which works out to a compound annual growth rate of 34.4%. In the June 2026 quarter, revenue grew 12.1% year on year to Rs 2,015 crore.<\/p>\n<p><strong>Roadmap:<\/strong> Backup power demand from data centres, telecom and infrastructure, a growing exports business and new alternative-fuel engines give it several tracks for growth. A large service network helps it hold on to customers across product cycles.<\/p>\n<p><strong>What to watch:<\/strong> Watch order intake from data centres and the pace of new product launches in cleaner fuels.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Concord_Biotech_Features_Among_These_Engine_Biotech_and_Airline_Software_Stocks\"><\/span><strong>Why Concord Biotech Features Among These Engine, Biotech and Airline Software Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the genset maker, drug ingredient and fare system shares on this list, Concord Biotech is a Gujarat-based biopharma company that makes fermentation-based active ingredients such as immunosuppressants, oncology drugs and anti-infectives for global pharma customers.<\/p>\n<p>Revenue rose from Rs 736 crore in FY22 to Rs 1,107 crore in FY26, a compound annual growth rate of 10.7%. Net profit grew from Rs 175 crore in FY22 to Rs 259 crore in FY26, which works out to a compound annual growth rate of 10.3%.<\/p>\n<p>In the June 2026 quarter, revenue grew 24.2% year on year to Rs 270 crore, while net profit rose 31.0% to Rs 57.7 crore. The company has a return on equity of 12.9%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 13,421 crore. The stock trades at a P\/E of 49.2, above the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company is among the leading global suppliers in its key immunosuppressant molecules and is moving into formulations and new fermentation products. Its backward integration and regulatory approvals support its position.<\/p>\n<p><strong>What to watch:<\/strong> Monitor the pace of new product introductions and the contribution from formulations.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Accelya_Solutions_India_Features_Among_These_Engine_Biotech_and_Airline_Software_Stocks\"><\/span><strong>Why Accelya Solutions India Features Among These Engine, Biotech and Airline Software Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Accelya Solutions India provides software and services to airlines, helping them manage revenue accounting, sales settlement and passenger-related processes for carriers around the world.<\/p>\n<p>Revenue rose from Rs 376 crore in FY22 to Rs 553 crore in FY26, a compound annual growth rate of 10.1%. Net profit grew from Rs 76.2 crore in FY22 to Rs 95.4 crore in FY26, which works out to a compound annual growth rate of 5.8%.<\/p>\n<p>The company has a return on equity of 38.1%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 1,422 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 17.6.<\/p>\n<p><strong>Roadmap:<\/strong> The company benefits from airlines modernising their technology and from strong growth in air travel. Long-term contracts with carriers provide repeat revenue.<\/p>\n<p><strong>What to watch:<\/strong> Follow new airline contracts, global air traffic and the pace of product upgrades.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Kirloskar_Oil_Engines_vs_Concord_Biotech_vs_Accelya_Solutions_India_on_Key_Financials\"><\/span><strong>Kirloskar Oil Engines vs Concord Biotech vs Accelya Solutions India on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three engine, biotech and airline software stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Kirloskar Oil Engines<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,049<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,772<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">558<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Concord Biotech<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">736<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,107<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">259<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Accelya Solutions India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">376<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">553<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">95.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.2%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Accelya Solutions India posts the highest return on equity in this group at 38.1%. Kirloskar Oil Engines combines the largest FY26 revenue at Rs 7,772 crore with the fastest revenue growth, a 17.7% compound annual rate. A useful habit with engine, biotech and airline software stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Engine_Biotech_and_Airline_Software_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Engine, Biotech and Airline Software Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these engine, biotech and airline software stocks, the main points are: Long-term genset maker, drug ingredient and fare system shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Production cycles.<\/strong> Vehicle output can vary with demand.<\/li>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Travel cycles.<\/strong> Bookings and occupancy follow travel demand.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter engine, biotech and airline software stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Engine_Biotech_and_Airline_Software_Stocks\"><\/span><strong>Final Thoughts on Engine, Biotech and Airline Software Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Engine, biotech and airline software stocks suit investors who prefer to study business strength before price moves. Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India each have a clear plan to grow. Based on the 11 November 2026 close, Kirloskar Oil Engines trades at Rs 1,632.4, Concord Biotech at Rs 597.2 and Accelya Solutions India at Rs 972.7.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track engine, biotech and airline software stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_engine_biotech_and_airline_software_stocks\"><\/span><strong>What are engine, biotech and airline software stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Engine, biotech and airline software stocks are listed companies that build diesel engines and generator sets for farms, industry and backup power, make fermentation based active pharmaceutical ingredients and finished medicines, and provide revenue, fares and operations software to airlines. Their earnings depend on equipment demand, pharma sourcing and airline technology spending. This list looks at three of them, Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_engine_biotech_and_airline_software_stocks_are_covered_in_this_list\"><\/span><strong>Which engine, biotech and airline software stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India. Based on the 11 November 2026 close, Kirloskar Oil Engines traded at Rs 1,632.4, Concord Biotech at Rs 597.2 and Accelya Solutions India at Rs 972.7. Their return on equity ranges from 12.9% to 38.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.1% to 17.7%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_engine_biotech_and_airline_software_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do engine, biotech and airline software stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Engine, biotech and airline software stocks have a strong roadmap in India because steady need for backup power and farm equipment, growing demand for specialty pharma ingredients and rising air travel keep widening the market for these companies. The main drivers are as follows. Engines and gensets. Farms and factories need reliable power. Fermentation pharma. Drug makers need dependable biotech inputs. Airline software. Airlines modernise fares and operations systems. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Kirloskar_Oil_Engines_performed_financially\"><\/span><strong>How has Kirloskar Oil Engines performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 4,049 crore in FY22 to Rs 7,772 crore in FY26, a compound annual growth rate of 17.7%. Net profit grew from Rs 171 crore in FY22 to Rs 558 crore in FY26, which works out to a compound annual growth rate of 34.4%. In the June 2026 quarter, revenue grew 12.1% year on year to Rs 2,015 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 1.48 and a market capitalisation of Rs 28,722 crore. The stock trades at a P\/E of 53.7, above the industry P\/E of 44.4. Looking ahead, backup power demand from data centres, telecom and infrastructure, a growing exports business and new alternative-fuel engines give it several tracks for growth. A large service network helps it hold on to customers across product cycles.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Concord_Biotech_performed_financially\"><\/span><strong>How has Concord Biotech performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 736 crore in FY22 to Rs 1,107 crore in FY26, a compound annual growth rate of 10.7%. Net profit grew from Rs 175 crore in FY22 to Rs 259 crore in FY26, which works out to a compound annual growth rate of 10.3%. In the June 2026 quarter, revenue grew 24.2% year on year to Rs 270 crore, while net profit rose 31.0% to Rs 57.7 crore. The company has a return on equity of 12.9%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 13,421 crore. The stock trades at a P\/E of 49.2, above the industry P\/E of 36.0. Looking ahead, the company is among the leading global suppliers in its key immunosuppressant molecules and is moving into formulations and new fermentation products. Its backward integration and regulatory approvals support its position.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Accelya_Solutions_India_performed_financially\"><\/span><strong>How has Accelya Solutions India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 376 crore in FY22 to Rs 553 crore in FY26, a compound annual growth rate of 10.1%. Net profit grew from Rs 76.2 crore in FY22 to Rs 95.4 crore in FY26, which works out to a compound annual growth rate of 5.8%. The company has a return on equity of 38.1%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 1,422 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 17.6. Looking ahead, the company benefits from airlines modernising their technology and from strong growth in air travel. Long-term contracts with carriers provide repeat revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_engine_biotech_and_airline_software_stocks\"><\/span><strong>What risks should investors check before buying engine, biotech and airline software stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying engine, biotech and airline software stocks. Production cycles. Vehicle output can vary with demand. Regulatory approvals. Plant inspections and approvals can affect supplies. Travel cycles. Bookings and occupancy follow travel demand. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_engine_biotech_and_airline_software_stocks_investment_advice\"><\/span><strong>Is this list of engine, biotech and airline software stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are engine, biotech and airline software stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Engine, biotech and airline software stocks are listed companies that build diesel engines and generator sets for farms, industry and backup power, make fermentation based active pharmaceutical ingredients and finished medicines, and provide revenue, fares and operations software to airlines. Their earnings depend on equipment demand, pharma sourcing and airline technology spending. This list looks at three of them, Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which engine, biotech and airline software stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India. Based on the 11 November 2026 close, Kirloskar Oil Engines traded at Rs 1,632.4, Concord Biotech at Rs 597.2 and Accelya Solutions India at Rs 972.7. Their return on equity ranges from 12.9% to 38.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 10.1% to 17.7%.\"}},{\"@type\":\"Question\",\"name\":\"Why do engine, biotech and airline software stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Engine, biotech and airline software stocks have a strong roadmap in India because steady need for backup power and farm equipment, growing demand for specialty pharma ingredients and rising air travel keep widening the market for these companies. The main drivers are as follows. Engines and gensets. Farms and factories need reliable power. Fermentation pharma. Drug makers need dependable biotech inputs. Airline software. Airlines modernise fares and operations systems. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Kirloskar Oil Engines performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 4,049 crore in FY22 to Rs 7,772 crore in FY26, a compound annual growth rate of 17.7%. Net profit grew from Rs 171 crore in FY22 to Rs 558 crore in FY26, which works out to a compound annual growth rate of 34.4%. In the June 2026 quarter, revenue grew 12.1% year on year to Rs 2,015 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 1.48 and a market capitalisation of Rs 28,722 crore. The stock trades at a P\/E of 53.7, above the industry P\/E of 44.4. Looking ahead, backup power demand from data centres, telecom and infrastructure, a growing exports business and new alternative-fuel engines give it several tracks for growth. A large service network helps it hold on to customers across product cycles.\"}},{\"@type\":\"Question\",\"name\":\"How has Concord Biotech performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 736 crore in FY22 to Rs 1,107 crore in FY26, a compound annual growth rate of 10.7%. Net profit grew from Rs 175 crore in FY22 to Rs 259 crore in FY26, which works out to a compound annual growth rate of 10.3%. In the June 2026 quarter, revenue grew 24.2% year on year to Rs 270 crore, while net profit rose 31.0% to Rs 57.7 crore. The company has a return on equity of 12.9%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 13,421 crore. The stock trades at a P\/E of 49.2, above the industry P\/E of 36.0. Looking ahead, the company is among the leading global suppliers in its key immunosuppressant molecules and is moving into formulations and new fermentation products. Its backward integration and regulatory approvals support its position.\"}},{\"@type\":\"Question\",\"name\":\"How has Accelya Solutions India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 376 crore in FY22 to Rs 553 crore in FY26, a compound annual growth rate of 10.1%. Net profit grew from Rs 76.2 crore in FY22 to Rs 95.4 crore in FY26, which works out to a compound annual growth rate of 5.8%. The company has a return on equity of 38.1%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 1,422 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 17.6. Looking ahead, the company benefits from airlines modernising their technology and from strong growth in air travel. Long-term contracts with carriers provide repeat revenue.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying engine, biotech and airline software stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying engine, biotech and airline software stocks. Production cycles. Vehicle output can vary with demand. Regulatory approvals. Plant inspections and approvals can affect supplies. Travel cycles. Bookings and occupancy follow travel demand. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of engine, biotech and airline software stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Engine, Biotech and Airline Software Stocks with a strong future roadmap: Kirloskar Oil Engines, Concord Biotech and Accelya Solutions India. Compare price, valuation, return on equity and revenue growth as of 11 November 2026.<\/p>\n","protected":false},"author":35,"featured_media":344581,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[15773,3803,22628,11240,22630,22632,22629,7052,22631],"class_list":["post-344582","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-accelya-solutions-india","tag-best-stocks","tag-biotech-and-airline-software-stocks","tag-concord-biotech","tag-drug-ingredient-and-fare-system-shares","tag-fermentation-api-and-travel-software-stocks","tag-genset-maker","tag-kirloskar-oil-engines","tag-power-engine"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["344581"],"rank_math_title":["Engine, Biotech and Airline Software Stocks"],"rank_math_description":["Compare 3 engine, biotech and airline software stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 11 Nov 2026."],"rank_math_focus_keyword":["engine, biotech and airline software stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-engines-and-gensets-maker-fermentation-based-pharma-maker-and-airline-software.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344582","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=344582"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344582\/revisions"}],"predecessor-version":[{"id":344583,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344582\/revisions\/344583"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/344581"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=344582"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=344582"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=344582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}